We are live on ! Find out more
AC

Athos Capital Portfolio holdings

AUM $324M
1-Year Est. Return 16.62%
This Fund
S&P 500
This Quarter Est. Return
-1.14%
1 Year Est. Return
+16.62%
3 Year Est. Return
+82.15%
5 Year Est. Return
+203.21%
10 Year Est. Return
AUM
$413M
AUM Growth
-$86.4M
Cap. Flow
-$84M
Cap. Flow %
-20.33%
Top 10 Hldgs %
38.04%
Holding
179
New
18
Increased
5
Reduced
5
Closed
38

Top Buys

Rank Stock Value
1
JOBS
51job Inc
JOBS
+$21.4M
2
JOYY
JOYY Inc
JOYY
+$9.76M
3
STMP
Stamps.com, Inc.
STMP
+$6.98M
4
FIVN icon
FIVE9
FIVN
+$5.97M
5
WBT
Welbilt, Inc.
WBT
+$5.86M

Sector Composition

Rank Sector Weight
1 Financials 25.08%
2 Industrials 14.12%
3 Technology 10.69%
4 Communication Services 9.56%
5 Materials 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPF
176
DELISTED
Foley Trasimene Acquisition Corp.
WPF
-50,000
Closed -$489K
ATIP
177
DELISTED
ATI Physical Therapy, Inc.
ATIP
-1,131
Closed -$540K
MBAC.WS
178
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
-66,666
Closed -$648K
GRA
179
DELISTED
W.R. Grace & Co.
GRA
-109,800
Closed -$7.59M

Similar funds

Athos Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Athos Capital held 179 positions worth $413M, down 17% from $499M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Athos Capital withdrew a net $84M in Q3 2021, closing 38 positions and reducing 5 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $33.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, Athos Capital opened a new position in 51job Inc worth $20.2M.

  • Athos Capital's largest Q3 2021 buy was 51job Inc: 290,511 shares worth $20.2M.
  • Athos Capital added most to Welbilt, Inc. in Q3 2021, an estimated $5.86M increase.
  • Athos Capital's biggest Q3 2021 reduction was Xilinx Inc, cutting an estimated $12.3M.
  • Athos Capital fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $33.2M.
  • Athos Capital's ten largest holdings make up 38% of its $413M portfolio in Q3 2021.
  • Athos Capital opened 18 new positions and closed 38 in Q3 2021.
  • Athos Capital's portfolio value fell 17% quarter-over-quarter to $413M.

Based on Athos Capital's 13F filing for Q3 2021, filed 12 Nov 2021.